KR20020038466A - 카르보스티릴 유도체의 제조방법 - Google Patents
카르보스티릴 유도체의 제조방법 Download PDFInfo
- Publication number
- KR20020038466A KR20020038466A KR1020010056733A KR20010056733A KR20020038466A KR 20020038466 A KR20020038466 A KR 20020038466A KR 1020010056733 A KR1020010056733 A KR 1020010056733A KR 20010056733 A KR20010056733 A KR 20010056733A KR 20020038466 A KR20020038466 A KR 20020038466A
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- structural formula
- sodium
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims description 19
- 125000005606 carbostyryl group Chemical group 0.000 title description 5
- 238000002360 preparation method Methods 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 26
- -1 2-(benzoylamino)- 2-(2-oxo-1,2-dihydroquinoline-4-ylmethyl) malonic acid ester Chemical class 0.000 claims abstract description 15
- 238000004519 manufacturing process Methods 0.000 claims abstract description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 9
- JINBYESILADKFW-UHFFFAOYSA-N aminomalonic acid Chemical compound OC(=O)C(N)C(O)=O JINBYESILADKFW-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims abstract description 4
- 239000000460 chlorine Substances 0.000 claims abstract description 4
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims abstract description 4
- 238000006243 chemical reaction Methods 0.000 claims description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 7
- 229960000583 acetic acid Drugs 0.000 claims description 7
- 239000012362 glacial acetic acid Substances 0.000 claims description 7
- 230000002194 synthesizing effect Effects 0.000 claims description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 239000003638 chemical reducing agent Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- 235000010288 sodium nitrite Nutrition 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 claims description 2
- 229910000105 potassium hydride Inorganic materials 0.000 claims description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 claims description 2
- 239000012279 sodium borohydride Substances 0.000 claims description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 239000012312 sodium hydride Substances 0.000 claims description 2
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- WPXPRJVFLONKAC-UHFFFAOYSA-N 2-benzamido-3-(2-oxo-1h-quinolin-4-yl)propanoic acid Chemical class C=1C(=O)NC2=CC=CC=C2C=1CC(C(=O)O)NC(=O)C1=CC=CC=C1 WPXPRJVFLONKAC-UHFFFAOYSA-N 0.000 abstract description 4
- 239000006227 byproduct Substances 0.000 abstract description 4
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 abstract 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical group [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 7
- BBAHJCUCNVVEQU-UHFFFAOYSA-N 4-(bromomethyl)-1h-quinolin-2-one Chemical compound C1=CC=C2C(CBr)=CC(=O)NC2=C1 BBAHJCUCNVVEQU-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- KTKBMOLVXVIHQA-UHFFFAOYSA-N diethyl 2-[(4-chlorobenzoyl)amino]propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)NC(=O)C1=CC=C(Cl)C=C1 KTKBMOLVXVIHQA-UHFFFAOYSA-N 0.000 description 3
- ISOLMABRZPQKOV-UHFFFAOYSA-N diethyl 2-acetamidopropanedioate Chemical compound CCOC(=O)C(NC(C)=O)C(=O)OCC ISOLMABRZPQKOV-UHFFFAOYSA-N 0.000 description 3
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- QYEMNJMSULGQRD-UHFFFAOYSA-N 1-methyl-2-quinolone Chemical compound C1=CC=C2C=CC(=O)N(C)C2=C1 QYEMNJMSULGQRD-UHFFFAOYSA-N 0.000 description 2
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 2
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- ALLWOAVDORUJLA-UHFFFAOYSA-N Rebamipida Chemical compound C=1C(=O)NC2=CC=CC=C2C=1CC(C(=O)O)NC(=O)C1=CC=C(Cl)C=C1 ALLWOAVDORUJLA-UHFFFAOYSA-N 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- IMTLPYCYJGUFHB-UHFFFAOYSA-N diethyl 2-[(4-chlorobenzoyl)amino]-2-[(2-oxo-1h-quinolin-4-yl)methyl]propanedioate Chemical compound C=1C(=O)NC2=CC=CC=C2C=1CC(C(=O)OCC)(C(=O)OCC)NC(=O)C1=CC=C(Cl)C=C1 IMTLPYCYJGUFHB-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- RXLGMBKGCJVHHZ-UHFFFAOYSA-N 2-hydroxyiminopropanedioic acid Chemical class ON=C(C(O)=O)C(O)=O RXLGMBKGCJVHHZ-UHFFFAOYSA-N 0.000 description 1
- 125000001999 4-Methoxybenzoyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C(*)=O 0.000 description 1
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 1
- IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical compound CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/08—Malonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
- 하기 구조식(2)로 표시되는 디알킬 페닐 유도체의 아미노말로네이트와 구조식(3)으로 표시되는 4-할로메틸-1H-퀴놀린-2-원을 반응시켜 구조식(4)으로 표시되는 2-(벤조일아미노)-2-(2-옥소-1,2-디하이드로퀴놀린-4-릴메틸)말론산에스터를 제조한 다음, 이 화합물을 선택적으로 탈탄산화 시켜 구조식(1)로 표시되는 2-(벤조일아미노)-3-(2-옥소-1,2-디하이드로퀴놀린-4-릴)프로피온산 유도체를 제조하는 방법.상기 구조식에서, R은 페닐, 4-클로로 페닐, 4-메톡시 페닐을 의미하고, R1, R2는 메틸, 또는 에틸을 의미하며, X는 염소 또는 브롬을 의미한다.
- 제 1항에 있어서, 구조식(4)화합물을 합성하는 과정에서 사용되는 용매는 메탄올 또는 에탄올 중에서 선택 사용하는 것을 특징으로 하는 제조 방법.
- 제 1항에 있어서, 구조식(4)를 합성하는 과정에서 사용되는 염기는 소디움아마이드, 수소화나트륨, 수소화칼륨 또는 소디움 메탈 중에서 선택 사용하는 것을 특징으로 하는 제조 방법.
- 제 1항에 있어서, 구조식(1)을 합성하는 탈탄산화 과정에서 사용되는 염기는 수산화나트륨, 탄산나트륨, 수산화칼륨 또는 탄산칼슘 중에서 선택사용하고, 산은 염산 또는 황산 중에서 선택 사용하는 것을 특징으로 하는 제조 방법.
- 제 1항에 있어서, 구조식(1)을 합성하는 반응의 온도는 80∼120℃인 것을 특징으로 하는 제조 방법.
- 말로네이트 화합물(8)을 빙초산/물 혼합용매에 용해 후 소디움나이트라이트를 가해 반응 중간체인 2-하이드록시이미노말로네이트 유도체를 만든 다음, 환원제를 사용하여 아민으로 바꾸고 벤조일 유도체를 붙여 구조식(2)를 얻는 제조 방법.상기 구조식에서, R,R1,R2의 정의는 제1항과 같다.
- 제 6항에 있어서, 구조식(2)의 화합물을 합성하는 과정에서 사용되는 용매는 물, 빙초산, 에테르, 디클로로메탄, 디클롤로에탄 또는 테트라하이드로퓨란 중에서 선택 사용하는 것을 특징으로 하는 제조 방법.
- 제 6항에 있어서, 구조식(2)의 화합물을 합성하는 과정에서 사용되는 환원제는 수소화붕소 나트륨, 수소화리튬 알루미늄, 라네이 니켈, 또는 아연 중에서 선택 사용하는 것을 특징으로 하는 제조 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010056733A KR20020038466A (ko) | 2001-09-14 | 2001-09-14 | 카르보스티릴 유도체의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010056733A KR20020038466A (ko) | 2001-09-14 | 2001-09-14 | 카르보스티릴 유도체의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20020038466A true KR20020038466A (ko) | 2002-05-23 |
Family
ID=19714283
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020010056733A Ceased KR20020038466A (ko) | 2001-09-14 | 2001-09-14 | 카르보스티릴 유도체의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20020038466A (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100520184B1 (ko) * | 2002-10-11 | 2005-10-10 | 한미약품 주식회사 | 레바미파이드의 개선된 제조방법 |
KR100638171B1 (ko) * | 2005-03-25 | 2006-10-26 | 건일제약 주식회사 | 2,n-디메틸-n-(3,3-디페닐프로필)-1-아미노-2-프로판올의제조방법 |
KR100766578B1 (ko) * | 2001-12-18 | 2007-10-11 | 동화약품공업주식회사 | 레바미피드의 제조방법 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR900006401A (ko) * | 1988-10-26 | 1990-05-08 | 모리스 트롤리에 | 장애된 디아민으로부터 제조된 이미드기 함유 중합체 |
JPH03145468A (ja) * | 1989-10-28 | 1991-06-20 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体の製造法 |
KR20020068287A (ko) * | 2001-02-20 | 2002-08-27 | 경동제약 주식회사 | 2-(4-클로로벤조일아미노)-3-[2(1h)-퀴놀리논-4-일]프로피온산의 제조방법 |
-
2001
- 2001-09-14 KR KR1020010056733A patent/KR20020038466A/ko not_active Ceased
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR900006401A (ko) * | 1988-10-26 | 1990-05-08 | 모리스 트롤리에 | 장애된 디아민으로부터 제조된 이미드기 함유 중합체 |
JPH03145468A (ja) * | 1989-10-28 | 1991-06-20 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体の製造法 |
KR20020068287A (ko) * | 2001-02-20 | 2002-08-27 | 경동제약 주식회사 | 2-(4-클로로벤조일아미노)-3-[2(1h)-퀴놀리논-4-일]프로피온산의 제조방법 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100766578B1 (ko) * | 2001-12-18 | 2007-10-11 | 동화약품공업주식회사 | 레바미피드의 제조방법 |
KR100520184B1 (ko) * | 2002-10-11 | 2005-10-10 | 한미약품 주식회사 | 레바미파이드의 개선된 제조방법 |
KR100638171B1 (ko) * | 2005-03-25 | 2006-10-26 | 건일제약 주식회사 | 2,n-디메틸-n-(3,3-디페닐프로필)-1-아미노-2-프로판올의제조방법 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004518737A (ja) | 2−(4−クロロベンゾイルアミノ)−3−[2(1h)−キノールリノン−4−イル]プロピオン酸の製造方法 | |
EP0990647B1 (en) | Process for producing quinolone derivatives | |
KR20020038466A (ko) | 카르보스티릴 유도체의 제조방법 | |
KR100413172B1 (ko) | 퀴놀리논 유도체의 제조방법 | |
JP2002512223A (ja) | 純粋な鏡像体であるn−メチル−n−[(1s)−1−フェニル−2−((3s)−3−ヒドロキシピロリジン−1−イル)エチル]−2,2−ジフェニルアセトアミドの製造方法 | |
US5712393A (en) | Derivatives of 2-aminobenzenesulphonic acid and of 2-aminobenzenesulphonyl chloride, their preparation and their use as synthetic intermediates | |
US5532381A (en) | Process for preparing pyrrolizine derivatives | |
JP2004231521A (ja) | 3−クロロ−5−ニトロトルエンの合成方法 | |
JP4181233B2 (ja) | ピロリジン−2,4−ジオン誘導体の製法 | |
JPH09169733A (ja) | 4−トリフルオロメチルニコチン酸の製造方法 | |
JP2716243B2 (ja) | N―ベンジル―3―ヒドロキシスクシンアミド酸およびその製造法 | |
US5675034A (en) | Process for preparing 2-(p-fluorophenyl)-2 methyl-propionic acid and 3-(p-fluorophenyl)-2-methylpropionic acid derivatives | |
USH1737H (en) | 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same | |
JP2003505355A (ja) | 5−および/または6−置換−2−ヒドロキシ安息香酸エステルの製造方法 | |
JP2002275138A (ja) | 2−アミノインダン誘導体の製造方法およびその中間体 | |
JP3013760B2 (ja) | 4−ヒドロキシ−2−ピロリドンの製法 | |
JPH02255673A (ja) | 4―アリールオキシー1,3―ベンゾジオキソール類およびその製造方法 | |
JPWO2005063678A1 (ja) | フェニル酢酸誘導体の製造方法 | |
JPH0737444B2 (ja) | 4−ベンジロキシ−3−ピロリン、その製造方法およびテトラム酸の製造への使用 | |
JPH05221947A (ja) | シクロプロパン誘導体の製法 | |
JP3918468B2 (ja) | 3,3−ビス(アルコキシカルボニル−メチルチオ)プロピオニトリル及びその製造方法 | |
JPH03176463A (ja) | ピロリジノール誘導体およびその製法 | |
JPH069518A (ja) | N−トリフェニルメチル−デヒドロアラニン誘導体及びその製造方法 | |
JPH06184108A (ja) | 5−クロロオキシインドールの製造方法 | |
JPH11116546A (ja) | 7−メトキシ−2−アミノテトラリンカーバメート及びその製造方法並びにそれを用いた7−メトキシ−2−アミノテトラリンの光学純度向上方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20010914 |
|
PA0201 | Request for examination | ||
G15R | Request for early publication | ||
PG1501 | Laying open of application |
Comment text: Request for Early Opening Patent event code: PG15011R01I Patent event date: 20020513 |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20030929 Patent event code: PE09021S01D |
|
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20040131 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20030929 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |